Cite
Clyde A, Galanie S, Kneller DW, et al. High-Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Noncovalent Inhibitor. J Chem Inf Model. 2021;62(1):116-128doi: 10.1021/acs.jcim.1c00851.
Clyde, A., Galanie, S., Kneller, D. W., Ma, H., Babuji, Y., Blaiszik, B., Brace, A., Brettin, T., Chard, K., Chard, R., Coates, L., Foster, I., Hauner, D., Kertesz, V., Kumar, N., Lee, H., Li, Z., Merzky, A., Schmidt, J. G., Tan, L., Titov, M., Trifan, A., Turilli, M., Van Dam, H., Chennubhotla, S. C., Jha, S., Kovalevsky, A., Ramanathan, A., Head, M. S., & Stevens, R. (2022). High-Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Noncovalent Inhibitor. Journal of chemical information and modeling, 62(1), 116-128. https://doi.org/10.1021/acs.jcim.1c00851
Clyde, Austin, et al. "High-Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Noncovalent Inhibitor." Journal of chemical information and modeling vol. 62,1 (2022): 116-128. doi: https://doi.org/10.1021/acs.jcim.1c00851
Clyde A, Galanie S, Kneller DW, Ma H, Babuji Y, Blaiszik B, Brace A, Brettin T, Chard K, Chard R, Coates L, Foster I, Hauner D, Kertesz V, Kumar N, Lee H, Li Z, Merzky A, Schmidt JG, Tan L, Titov M, Trifan A, Turilli M, Van Dam H, Chennubhotla SC, Jha S, Kovalevsky A, Ramanathan A, Head MS, Stevens R. High-Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Noncovalent Inhibitor. J Chem Inf Model. 2022 Jan 10;62(1):116-128. doi: 10.1021/acs.jcim.1c00851. Epub 2021 Nov 18. PMID: 34793155; PMCID: PMC8610012.
Copy
Download .nbib